Literature DB >> 9575044

Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.

M T Migawa1, J L Girardet, J A Walker, G W Koszalka, S D Chamberlain, J C Drach, L B Townsend.   

Abstract

Several 2-substituted alpha-D- and alpha-L-lyxofuranosyl and 5-deoxylyxofuranosyl derivatives of 5,6-dicholro-2-(isopropylamino)-1-(beta-L-ribofuranosyl) benzimidazole (1263W94) and 2,5,6-trichloro-1(beta-D-ribofuranosyl)benzimidazole (TCRB) were synthesized and evaluated for activity against two herpesviruses (HSV-1 and HCMV) and for their cytotoxicity against HFF and KB cells. Condensation of 1,2,3,5-tetra-O-acetyl-L-lyxofuranose (2a) with 2,5,6-trichlorobenzimidazole (1) yielded the alpha-nucleoside 3a. The 2-bromo derivative and 2-methylamino derivative were prepared by treatment of 3a with HBr followed by deprotection or from methylamine, respectively. Compound 3a was deprotected and the resultant nucleoside used to prepare the 2-cyclopropylamino and 2-isopropylamino derivatives. The 2-alkylthio nucleosides were prepared by condensing 2a with 5,6-dichlorobenzimidazole-2-thione followed by deprotection. Alkylation of this adduct gave the 2-methylthio and 2-benzylthio derivatives. Condensation of 5-deoxy-1,2,3-tri-O-acetyl-L-lyxofuranosyl, prepared from L-lyxose, with 1 or 2-bromo-5,6-dichlorobenzimidazole (15), followed by deprotection, gave the 2-chloro or 2-bromo-5'-deoxylyxo-furanosyl derivative, respectively. The cyclopropylamino derivative was prepared from the 2-chloro derivative. All D-isomers were prepared in an analogous fashion from D-lyxose. Either compounds were inactive against HSV-1 or weak activity was poorly separated from cytotoxicity. In contrast, the 2-halogen derivatives in both the alpha-lyxose and 5-deoxy-alpha-lyxose series were active against the Towne strain of HCMV. The 5-deoxy alpha-L analogues were the most active, IC50's = 0.2-0.4 microM, plaque assay; IC90's = 0.2-2 microM, yield reduction assay. All of the 2-isopropylamino or 2-cyclopropylamino derivatives were less active (IC50's = 60-100 microM, plaque assay; IC90's = 17-100 microM, yield reduction assay) and were not cytotoxic. The methylamino, thio, and methylthio derivatives were neither active nor cytotoxic. The benzylthio derivatives were weakly active, but this activity was poorly separated from cytotoxicity. The alpha-lyxose L-isomers were more active in a plaque assay against the AD169 strain of HCMV compared to the Towne strain, thereby providing additional evidence of antiviral specificity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575044     DOI: 10.1021/jm970545c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus.

Authors:  Edward Gershburg; Salvatore Raffa; Maria Rosaria Torrisi; Joseph S Pagano
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

2.  Benzimidazole analogs inhibit human herpesvirus 6.

Authors:  Mark N Prichard; Samuel L Frederick; Shannon Daily; Katherine Z Borysko; Leroy B Townsend; John C Drach; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2011-02-07       Impact factor: 5.191

3.  Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.

Authors:  David L Evers; Gloria Komazin; Roger G Ptak; Dongjin Shin; Brian T Emmer; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

4.  Rhesus cytomegalovirus is similar to human cytomegalovirus in susceptibility to benzimidazole nucleosides.

Authors:  Thomas W North; Getachew Sequar; Leroy B Townsend; John C Drach; Peter A Barry
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

5.  Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides.

Authors:  Gloria Komazin; Leroy B Townsend; John C Drach
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

6.  Synthesis, Characterization, Thermal Properties, and Antimicrobial Activities of 5-(Diethylamino)-2-(5-nitro-1H-benzimidazol-2-yl)phenol and Its Transition Metal Complexes.

Authors:  Vikas S Padalkar; Vikas S Patil; Vinod D Gupta; Kiran R Phatangare; Prashant G Umape; N Sekar
Journal:  ISRN Org Chem       Date:  2011-07-12

7.  2-Chloro-methyl-1-methyl-1,3-benzimidazole.

Authors:  Jie Han; Jun Zhang; Qi Yang; Ming-Gao Zhao; Guang Fan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-23

8.  1-[4-(Prop-2-en-1-yl-oxy)benz-yl]-2-[4-(prop-2-en-1-yl-oxy)phen-yl]-1H-benzimidazole.

Authors:  Md Lutfor Rahman; Huey Chong Kwong; Mashitah Mohd Yusoff; Gurumurthy Hegde; Mohamed Ibrahim Mohamed Tahir
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-11-10

9.  Facile and efficient one-pot synthesis of benzimidazoles using lanthanum chloride.

Authors:  Yekkirala Venkateswarlu; Sudhagani Ramesh Kumar; Panuganti Leelavathi
Journal:  Org Med Chem Lett       Date:  2013-08-06

10.  Benzimidazole-1,2,3-triazole hybrid molecules: synthesis and evaluation for antibacterial/antifungal activity.

Authors:  Abdelaaziz Ouahrouch; Hana Ighachane; Moha Taourirte; Joachim W Engels; My Hassan Sedra; Hassan B Lazrek
Journal:  Arch Pharm (Weinheim)       Date:  2014-08-04       Impact factor: 3.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.